This inventor holds 8 USPTO granted patents and 1 published patent application. Top assignees: H. Lundbeck A/s, Synaptic Pharmaceutical Corporation. Active years: 2004-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Fresh Meadows, NY (US) (2004 - 2007)
- Flushing, NY (US) (2006 - 2009)
Company Filing History:
Years Active: 2004-2009
Title: Chien-An Chen: Innovator in Pharmaceutical Chemistry
Introduction
Chien-An Chen is a notable inventor based in Flushing, NY (US), recognized for his contributions to pharmaceutical chemistry. With a total of 8 patents to his name, he has made significant advancements in the field, particularly in the development of compounds that target specific receptors in the body.
Latest Patents
Among his latest patents is the invention of secondary amino anilinic piperidines as MCH1 antagonists and their uses. This invention focuses on compounds that act as selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The patent outlines a pharmaceutical composition that includes a therapeutically effective amount of the compound along with a pharmaceutically acceptable carrier. Additionally, it describes methods for reducing body mass and treating subjects suffering from depression, anxiety, and urinary disorders through the administration of these compounds. Another significant patent involves amino substituted aryloxybenzylpiperidine derivatives, which serve as ligands at the MCH1 receptor. This invention also provides a pharmaceutical composition and methods for treating depression, anxiety, and obesity.
Career Highlights
Chien-An Chen has worked with prominent companies in the pharmaceutical industry, including H. Lundbeck A/S and Synaptic Pharmaceutical Corporation. His work in these organizations has contributed to the development of innovative therapeutic solutions.
Collaborations
Throughout his career, Chen has collaborated with esteemed colleagues such as Mohammad R Marzabadi and Yu Jiang. These partnerships have further enhanced his research and development efforts in the pharmaceutical field.
Conclusion
Chien-An Chen's innovative work in pharmaceutical chemistry, particularly in the development of MCH1 antagonists, showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of various health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile